7 Results for "

Calu-6 cells

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "Calu-6 cells" in MCE Product Catalog:

Cat. No.: HY-137246
CAS No.: 2375815-63-5
Purity:  99.89%
Target:  

CD73

Research Areas:  

Cancer

CD73-IN-3 is a potent CD73 inhibitor (IC50=7.3 nM in Calu6 human cell assay). CD73-IN-3, example 2 extracted from patent WO2019168744 A1, has the potential for cancer research .
loading...
    loading...
Cat. No.: HY-148819A
Purity:  98.46%
Research Areas:  

Cancer

NH2-bicyclopentane-7-MAD-MDCPT hydrochloride (Formula I) is a topoisomerase I (TOP1) inhibitor. NH2-bicyclopentane-7-MAD-MDCPT hydrochloride is applicable to the synthesis of the ADC ABBV-969. NH2-bicyclopentane-7-MAD-MDCPT hydrochloride is used in research on lung adenocarcinoma and melanoma .
loading...
    loading...
Cat. No.: HY-144269
CAS No.: 2695506-82-0
Target:  

Raf

Research Areas:  

Cancer

SHR902275 is a potent, selective, and orally active RAF inhibitor targeting RAS mutant cancers. SHR902275 has IC50s of 1.6 nM, 10 nM, and 5.7 nM for cRAF, bRAF wt, and bRAF V600E, respectively. SHR902275 shows cell growth inhibition with GI50s of 1.5 and 0.17 nM, 0.4 nM and 0.32 nM for H358, A375, Calu6, and SK-MEL2 cells respectively .
loading...
    loading...
Cat. No.: HY-18165
CAS No.: 1221878-06-3
Target:  

LPL Receptor

Research Areas:  

Cancer

XL541 is a potent, selective S1P1 antagonist. XL541 inhibits GDP-GTP exchange. XL541 causes frank surface hemorrhaging of tumors. XL541 collaborates with Paclitaxel (HY-B0015) to exhibit antitumor activity against breast cancer and lung cancer .
loading...
    loading...
Cat. No.: HY-145402
CAS No.: 2640208-01-9
Target:  

CDK

Research Areas:  

Cancer

CDK7-IN-7 is a potent and selective CDK7 kinase inhibitor with an IC50 of <50 nM (Patent CN112661745A, compound T-01) .
loading...
    loading...
Cat. No.: HY-170343
CAS No.: 3033586-50-1
Target:  

PROTACs SWI/SNF Complex

Research Areas:  

Cancer

PROTAC SMARCA2 degrader-32 is a potent, selective SMARCA2 PROTAC degrader, with DC50 values of 1.3 nM and 94 nM against SMARCA2 and SMARCA4, respectively. PROTAC SMARCA2 degrader-32 exhibits IC50 against SMARCA2, SMARCA4 and the VHL E3 ubiquitin ligase of 30 nM, 63 nM and 25 nM, respectively. PROTAC SMARCA2 degrader-32 inhibits the growth of SMARCA4-deficient cancer cells. It can be used in research on cancers such as fibrosarcoma .
loading...
    loading...
Cat. No.: HY-181567
CAS No.: 3079150-70-9
Target:  

METTL3

Research Areas:  

Cancer

METTL3-IN-13 is a METTL3 inhibitor. METTL3-IN-13 is applicable to the research of multiple cancers such as hypopharyngeal squamous cell carcinoma and non-small cell lung cancer .
loading...
    loading...